As Next-Gen Sequencing Market Matures, Users Mull the '$1,000' Genome | GenomeWeb
The original version of this article neglected to fully identify Michael Rhodes, who is ABI’s applications manager for high-throughput discovery.
 
NEW YORK (GenomeWeb News) — It will be a while before any new sequencing technology platform delivers the $1,000 genome, but that hasn’t stopped researchers from mulling how or when that milestone might occur.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.